Skip to main content
Premium Trial:

Request an Annual Quote

DeCode Slashes Loss, See Slight Gain in Revenues

NEW YORK, Aug. 13 (GenomeWeb News) - DeCode Genetics slashed its net loss nearly by half for the second quarter and reported narrow revenue growth today.

 

The company had revenue of $10.5 million for the second quarter, ending June 30, compared to $9.4 million for the year-ago quarter. Net loss was $10.2 milllion, compared to $19.7 million for the same period in 2002.

 

The firm cut its research and development expenditures to $16.7 million for the quarter, compared to $24 million for the second quarter, 2002.

 

The Iceland-based firm said it has $77 million in cash and cash equivalents at the close of the quarter on June 30.

 

The company said it had $12.7 million in deferred revenue, which will be recognized in future reporting periods.

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.